Form 4: CervoMed Inc. CEO John J. Alam Acquires 60,000 Stock Options
SEC Form 4 Filing
CervoMed Inc.'s CEO, John J. Alam, acquired 60,000 stock options on February 4, 2025, according to a Form 4 filing.
Summary
- John J. Alam, CEO and President of CervoMed Inc., acquired 60,000 stock options on February 4, 2025.
- The exercise price of these options is $2.3.
- The options vest in 36 equal monthly installments starting February 28, 2025.
- The options expire on February 4, 2035.
- Following the transaction, Alam directly owns 60,000 derivative securities.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it simply reports an insider transaction. The acquisition of stock options by the CEO could be seen as a positive sign, but without further context, it's difficult to assess the overall impact.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency regarding insider transactions in publicly traded companies. This filing indicates a transaction by a key executive of CervoMed Inc.
Stakeholder Impact
- Shareholders may view the CEO's acquisition of stock options as a sign of confidence in the company's future prospects.
Key Dates
| Date | Description |
|---|---|
| 02/04/2025 | Date of the stock option transaction. |
| 02/14/2025 | Date of the Form 4 filing. |
| 02/28/2025 | Commencement date for the monthly vesting of the stock options. |
| 02/04/2035 | Expiration date of the stock options. |
Keywords
Form 4, CervoMed Inc., Stock Options, Insider Trading, John J. Alam, CRVO, CEO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.